Fig. 3From: Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foodsAntibacterial activity of bacteriocin-like inhibitory substance (BLIS) extracted from CYLB30 (A) and CYLB47 (B). Six pathogenic bacteria, including Salmonella enterica serovar Choleraesuis, E. coli, K. pneumoniae, P. aeruginosa, E. faecium,and S. aureus, were treated with BLIS. Error bars represent the standard deviation of triplicates. The bacterial viability of pathogens was compared to a negative control without BLIS treatment. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ns, no significant differenceBack to article page